Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer

Abstract excerpt

BACKGROUND: Gastric cancer (GC) is the second most common cause of cancer mortality world-wide. In recent years, aberrant SOX11 expression has been observed in various solid and hematopoietic malignancies, including GC. In addition, it has been reported that SOX11 expression may serve as an independent prognostic factor for the survival of GC patients. Here, we assessed the SOX11 gene promoter methylation status...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Cells and Metastasis
• Share to Epigenetics and DNA Methylation
• Share to Wnt/β-catenin signaling in development and cancer